Enrollment for Phase 2 MOMENTUM Trial Expected to Be Completed in Q1 2027 Phase 1b Trial of Cemsidomide in Combination with Elranatamab on Track to Initiate in Q2 2026 WATERTOWN, Mass., Feb. 23, 2026 ...

WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, ...

We release Qwen3-ASR, a family that includes two powerful all-in-one speech recognition models that support language identification and ASR for 52 languages and dialects, as well as a novel ...

Cemsidomide Phase 2 MOMENTUM Trial On Track to Initiate in Q1 2026; Recommended Phase 2 Dose is 100 µg Cemsidomide Phase 1b Trial in Combination With Elranatamab On Track to Initiate in Q2 2026 ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Image source: The Motley Fool. Grupo Aeroportuario del Sureste announced a $295 million acquisition of URW Airports, targeting major U.S. terminals and advancing its global expansion strategy.

Good day, ladies and gentlemen, and welcome to ASUR's Third Quarter 2025 Results Conference Call. My name is Latanya, and I'll be your operator. [Operator Instructions] As a reminder, today's call is ...

# International endpoint key export DASHSCOPE_API_KEY="sk-..." Qwen3-ASR-Toolkit turns Qwen3-ASR-Flash into a practical long-audio pipeline by combining VAD-based segmentation, FFmpeg normalization ...

GUITION JC4880P433 is a 4.3-inch capacitive touch display development board built around the GUITION JC-ESP32P4-M3 ESP32-P4 and ESP32-C6 module, which we have also seen used in the JC-ESP32P4-M3-DEV ...